Previously treated cases tested for RR-/MDR-TB in Africa (WHO region)

Africa (WHO region): Previously treated cases tested for RR-/MDR-TB was 78.0% in 2024. ◆ Volatile

Latest (2024)
78.0%
Change on year
down 3.7%
Rank
8th
of 11 groups
All-time high
84.0%
in 2020
All-time low
1.6%
in 2006
Years of data
20
2005–2024

Previously treated cases tested for RR-/MDR-TB in Africa (WHO region), 2005–2024

0204060802005201420242005: 3.12006: 1.62007: 5.32008: 7.12009: 32010: 2.92011: 2.92012: 4.12013: 9.62014: 332015: 652016: 292017: 422018: 722019: 612020: 842021: 822022: 722023: 812024: 78

Source: World Health Organization, Global Health Observatory.

Analysis

Africa (WHO region) recorded 78.0% for previously treated cases tested for rr-/mdr-tb in 2024.

That represents a change of down 3.7% on the previous year and up 136.4% over ten years.

Over the whole period, previously treated cases tested for rr-/mdr-tb in Africa (WHO region) peaked at 84.0% in 2020 and was at its lowest, 1.6%, in 2006.

The series is highly variable year to year, so single readings are best treated with caution.

Previously treated cases tested for RR-/MDR-TB in Africa (WHO region), year by year

Annual values for Previously treated cases tested for RR-/MDR-TB (%) in Africa (WHO region), 2005 to 2024.
Year Value Change
2005 3.1%
2006 1.6% -48.4%
2007 5.3% +231.2%
2008 7.1% +34.0%
2009 3.0% -57.7%
2010 2.9% -3.3%
2011 2.9% +0.0%
2012 4.1% +41.4%
2013 9.6% +134.1%
2014 33.0% +243.8%
2015 65.0% +97.0%
2016 29.0% -55.4%
2017 42.0% +44.8%
2018 72.0% +71.4%
2019 61.0% -15.3%
2020 84.0% +37.7%
2021 82.0% -2.4%
2022 72.0% -12.2%
2023 81.0% +12.5%
2024 78.0% -3.7%

Averages by decade

DecadeAverage LowestHighest Years
2000s 4.0% 1.6% 7.1% 5
2010s 32.1% 2.9% 72.0% 10
2020s 79.4% 72.0% 84.0% 5

More health data for Africa (WHO region)

All data for Africa (WHO region) →

Frequently asked questions

What is previously treated cases tested for rr-/mdr-tb in Africa (WHO region)?
Previously treated cases tested for rr-/mdr-tb in Africa (WHO region) was 78.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest previously treated cases tested for rr-/mdr-tb recorded in Africa (WHO region)?
The highest recorded value was 84.0% in 2020.
What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Africa (WHO region)?
The lowest recorded value was 1.6% in 2006.
How does Africa (WHO region) rank for previously treated cases tested for rr-/mdr-tb?
Africa (WHO region) ranks 8th out of 11 groups with data for 2024.
Is previously treated cases tested for rr-/mdr-tb rising or falling in Africa (WHO region)?
Over the last ten years it is up 136.4%. The long-run trend across the full record is volatile.
Where does this Africa (WHO region) data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Previously treated cases tested for RR-/MDR-TB in Africa (WHO region). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 September 2026, from https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/africa-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/africa-who-region/">Previously treated cases tested for RR-/MDR-TB in Africa (WHO region)</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed